Breaking News

Advocates sound an alarm on telehealth addiction treatment restrictions; obesity could cost $4 trillion by 2035

March 2, 2023
Janice Morales-Ferrer at her home in Newton, Mass.
Vanessa Leroy for STAT

Same patient, same drug, same insurer — coverage denied

A patient faced paying almost $5,000 for infusions after her insurer denied coverage — even though it covered the drug before.

By Tara Bannow


Advocates, lawmakers warn that Biden telehealth rule will worsen opioid crisis

A DEA proposal would require an in-person examination for telehealth patients in order for them to stay on buprenorphine for longer than 30 days.

By Lev Facher


Listen: The next CRISPR fight, cheaper insulin, & an FDA shuffle

Who invented CRISPR 2.0? What happens when a drug company actually lowers prices? And is Novavax going to survive? STAT's podcast covers all that and more.

By Damian Garde and Meg Tirrell and Adam Feuerstein



Adobe

Report: Obesity could cost the world over $4 trillion a year by 2035

Over half the world's population will be either overweight or have obesity by 2035, according to the World Obesity Federation.

By Julia Belluz


Opinion: New analysis: CMS vastly overestimates hospital price transparency efforts

A CMS report that 70% of hospitals are transparently publishing their prices is wrong. Only 25% are complying with the two key rules.

By Cynthia A. Fisher


How policymakers could tweak HIPAA to better protect abortion records

HIPAA largely doesn't prevent law enforcement from being able to access health records on abortion or other reproductive care.

By Avani Kalra — Medill News Service


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments